Trial Information
A Randomized Controlled Trial of Light Therapy on Biomarkers, Sleep/Wake Activity, and Quality of Life in Individuals With Post-treatment Cancer-related Fatigue
Inclusion Criteria:
- English speaking
- Non metastatic cancer
- At least 3 months post chemotherapy/radiation treatment (hormone treatment ok)
- Meets criteria for cancer-related fatigue
Exclusion Criteria:
- Under 18 years of age
- Presence of a sleep disorder other than insomnia or hypersomnia
- Shift work
- Presence of an Axis-I psychiatric condition
- Presence of a medical condition that may impact levels of fatigue
- Presence of conditions contraindicated to the use of light therapy or
photosensitizing medications
- Randomization refusal
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Outcome Measure:
Change in fatigue symptoms from baseline to post-treatment
Outcome Time Frame:
Baseline, after each treatment week (each week for 4 weeks), and at week 6
Safety Issue:
No
Principal Investigator
Tavis S Campbell, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Calgary
Authority:
Canada: Ethics Review Committee
Study ID:
10003569
NCT ID:
NCT01780623
Start Date:
January 2013
Completion Date:
March 2014
Related Keywords:
- Cancer
- fatigue
- sleep
- quality of life
- light
- cancer
- Fatigue